PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0223P0026Reagents to include chemistry immunology — Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch holds $2.4M across 8 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

W40m Rhco Pacific
Awarding office
Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch
Recipient
Sep 30, 2026
PoP end
$2M
Obligated
$2.7M
Potential
325413
NAICS
6515
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch — $90

Contract facts

NONE
Contract numberW81K0223P0026
Also listed asW81K02-23-P-0026
AgencyW40m Rhco Pacific
Awarding officeW40m Rhco Pacific
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentOrtho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch
CAGE767DF
UEIJNSJRDQQH2J6
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6515
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
Related solicitationW81K0223Q0004
PoP startJul 1, 2023
PoP end (current)Sep 30, 2026
PoP end (w/ options)Sep 30, 2027
Obligated$2M
Current value$2M
Potential value$2.7M

REAGENTS TO INCLUDE CHEMISTRY/IMMUNOLOGY ANALYZERS FOR BRAIN D. ALLGOOD ARMY COMMUNITY HOSPITAL, KOREA. is a federal NONE award for W40m Rhco Pacific held by Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch. Estimated value $2.7M ($2M obligated). Current period of performance ends Sep 30, 2026 (potential Sep 30, 2027). Last award drew 1 bidder. Related solicitation W81K0223Q0004.

REAGENTS TO INCLUDE CHEMISTRY/IMMUNOLOGY ANALYZERS FOR BRAIN D. ALLGOOD ARMY COMMUNITY HOSPITAL, KOREA.

Recompete timing

Public
Expiring in 23 days

Current PoP ends Sep 30, 2026 (23 days remaining). Agencies typically plan 12–18 months ahead — at 0.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch$2.4M obligated across 8 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)
Department of Defense (DOD)$2.4M · 100% of firm total
Open full company profile

Related awards

Same incumbent
W81K0225FA115
VITROS XT7600 REAGENTS FOR 51ST MDG, OSAN KOREA
$233K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W81K0223P0026?

W81K0223P0026 (Reagents to include chemistry immunology) is a W40m Rhco Pacific award with a potential value of $2.7M, currently held by Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81K02-23-P-0026?

W81K02-23-P-0026 is the dashed form of PIID W81K0223P0026 (Reagents to include chemistry immunology), held by Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81K0223P0026?

W40m Rhco Pacific awarded W81K0223P0026 to Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch (potential $2.7M).

Who is the incumbent on W81K0223P0026?

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch is the incumbent with $2.4M across 8 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch’s W81K0223P0026 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on W81K0223P0026 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W81K0223P0026